BRIDGEWAY CAPITAL MANAGEMENT, LLC
Position in BDTX — Black Diamond Therapeutics, Inc.
CIK 1107261
HOUSTON, TX
Position in BDTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,541,006
+$1,119,887 QoQ
Shares Held
723,477
+317.5% QoQ
Ownership
1.26%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BDTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $59,315,164 across 112 Biotechnology names. BDTX ranks #6 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GLUE |
Monte Rosa Therapeutics, Inc.
|
528,698 | $8,697,082 | |
| 2 | PBYI |
Puma Biotechnology, Inc.
|
775,341 | $4,954,428 | |
| 3 | EXEL |
Exelixis, Inc.
|
66,100 | $2,835,029 | |
| 4 | KROS |
Keros Therapeutics, Inc.
|
195,017 | $2,152,987 | |
| 5 | SGMT |
Sagimet Biosciences Inc.
|
299,641 | $1,565,624 | |
| 6 | BDTX |
Black Diamond Therapeutics, Inc.
This page
|
723,477 | $1,541,006 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
22,000 | $1,498,860 | |
| 8 | KYTX |
Kyverna Therapeutics, Inc.
|
149,900 | $1,293,637 |
All Filings in BDTX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,541,006 | 723,477 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $421,119 | 173,300 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $372,557 | 98,300 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $243,784 | 98,300 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $113,305 | 73,100 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $309,444 | 144,600 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $649,020 | 149,200 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $806,180 | 173,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $877,110 | 173,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $539,520 | 192,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $363,055 | 126,500 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $378,750 | 75,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $141,750 | 75,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $225,000 | 125,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $211,250 | 125,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $160,392 | 65,200 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $213,844 | 77,200 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||